Valuation: Bio-View Ltd

Market Cap 8.03M 0 2.55M 2.29M 2.1M 1.91M 3.56M 243M 3.63M 25.09M 10.07M 128M 9.59M 9.38M 402M P/E 2024
-11.7x
P/E 2025 -1.48x
Enterprise Value 3.6M 0 1.15M 1.03M 944K 855K 1.6M 109M 1.63M 11.26M 4.52M 57.24M 4.3M 4.21M 181M EV / Sales 2024
1.04x
EV / Sales 2025 0.9x
Free-Float
53.05%
Yield 2024 *
-
Yield 2025 -
1 day+10.73%
1 week+30.46%
Current month-11.90%
1 month-11.90%
3 months-26.53%
6 months-59.55%
Current year-60.28%
1 week 5,160
Extreme 5160
6,665
1 month 4,890
Extreme 4890
7,537
Current year 4,890
Extreme 4890
29,400
1 year 4,890
Extreme 4890
29,400
3 years 4,890
Extreme 4890
37,000
5 years 4,890
Extreme 4890
48,000
10 years 4,890
Extreme 4890
51,500
Manager TitleAgeSince
Corporate Officer/Principal 64 22/03/2009
Director of Finance/CFO 44 01/12/2020
Chief Operating Officer 50 01/01/2011
Director TitleAgeSince
Chairman 87 16/03/2000
Director/Board Member 70 28/06/2022
Director/Board Member 63 01/06/2015
Change 5-day change 1-year change 3-year change Capi.($)
+10.73%+30.46%-56.92%-79.31% 2.58M
-2.36%+3.35%+25.20%+60.41% 262B
-2.66%+0.39%+7.60%+25.01% 167B
-3.20%-3.69%-17.82%+68.51% 156B
-1.90%-8.35%-58.36%-16.33% 61.87B
-1.97%+3.97%+10.94%+48.51% 54.44B
0.00%+2.46%-11.97%-6.29% 53.3B
-4.11%+1.01%+21.94%+72.80% 51.07B
-0.09%-3.78%+9.05%+63.35% 50.25B
-4.33%+1.80%+34.69%+95.12% 47.17B
Average -0.98%+3.50%-3.56%+33.18% 90.26B
Weighted average by Cap. -2.44%+2.44%+5.16%+48.03%

Financials

2024 2025
Net sales 25.66M 0 8.16M 7.31M 6.72M 6.09M 11.39M 775M 11.6M 80.18M 32.19M 408M 30.63M 29.98M 1.29B 19.93M 0 6.34M 5.68M 5.22M 4.73M 8.85M 602M 9.01M 62.29M 25M 317M 23.8M 23.29M 999M
Net income -3.15M -0 -1M -897K -825K -748K -1.4M -95.09M -1.42M -9.84M -3.95M -50.02M -3.76M -3.68M -158M -15.33M -0 -4.88M -4.37M -4.02M -3.64M -6.81M -463M -6.93M -47.92M -19.24M -244M -18.31M -17.92M -768M
Net Debt -8.96M -0 -2.85M -2.55M -2.35M -2.13M -3.98M -271M -4.05M -28M -11.24M -142M -10.7M -10.47M -449M -4.43M -0 -1.41M -1.26M -1.16M -1.05M -1.96M -134M -2M -13.83M -5.55M -70.33M -5.28M -5.17M -222M
Projected Income Statement - Annual - Bio-View Ltd
Logo Bio-View Ltd
Bio-View Ltd. is an Israel-based company that operates within the medical devices industry. The Company focuses on developing, manufacturing, and marketing automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories. One of the key products offered by the Company is the Accord Plus. This product is an automatic fluorescent imaging system that scans, analyzes, and sorts a range of Fluorescence In Situ Hybridization (FISH) and karyotype samples in real-time. The primary goal of this technology is to facilitate the identification of various chromosomal aberrations, such as amplifications, translocations, inversions, and deletions, under fluorescent light.
Employees
30
Date Price Change Volume
30/10/26 ILA 6,634.00 +10.73% 195
29/10/26 ILA 5,991.00 +4.46% 25
28/10/26 ILA 5,735.00 +7.24% 15
26/10/26 ILA 5,348.00 +5.17% 510
23/10/26 ILA 5,085.00 +1.68% 140
  1. Stock Market
  2. Stocks
  3. BIOV Stock